Human polyomaviruses in psoriasis patients on biologic treatment
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F23%3A10468434" target="_blank" >RIV/00216208:11310/23:10468434 - isvavai.cz</a>
Result on the web
<a href="https://escv2023.org/index.php/abstract/" target="_blank" >https://escv2023.org/index.php/abstract/</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Human polyomaviruses in psoriasis patients on biologic treatment
Original language description
Biologic therapy poses a higher risk of viral infection for patients, however current knowledge of human polyomavirus infection in psoriasis patients is stilllimited. In this study, we evaluate the prevalence of BK polyomavirus (BKPyV), JC polyomavirus (JCPyV) and Merkel cell polyomavirus (MCPyV) in the group of psoriasis patients treated with biologics or topical therapy.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
10607 - Virology
Result continuities
Project
<a href="/en/project/LX22NPO5103" target="_blank" >LX22NPO5103: National Institute of Virology and Bacteriology</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů